Taken together, we demonstrate here for the first time a regulatory axis miR‐152‐5p/FBXL7 in glioma tumorigenesis and indicate that FBXL7 and miR‐152‐5p may be a potential treatment target for glioma, singly or combined with TMZ. The gene discussed is FBXL7; the disease is central nervous system cancer.